DELRAY BEACH, Fla., Aug. 23, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today its second quarter 2011 operational highlights and continued execution of its business plan, including the acquisition of MicroFluidic Systems, exit from a non-core business and FDA submission of its first diabetes management product.
